Tolerability of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch: a multicenter, retrospective study - Salzmann, Martin; Wald, Alexander; Stege, Henner; Loquai, Carmen; Zimmer, Lisa; Hayani, Kinan M.; Heinzerling, Lucie; Gutzmer, Ralf; Enk, Alexander; Hassel, Jessica C. (Cancers, 2023)
Gesehen am 07.12.2023